Partneringdesk Deals and alliances in central nervous system diseases published by Pharmalicensing Ltd. in April, 2006. This report consists of 1080 pages and the price starts from US $ 2495.
Abstract
Partneringdesk Deals and alliances in central nervous system diseases
Partneringdesk deals and alliances in central nervous system diseases provides
an in-depth view of over 1100 deals and alliances announced in central nervous
system diseases between 2001 and 2006, in a clear and accessible PDF format.
Introduction
A diagrammatical and analytical summary of the deals and dealmakers in the
therapy area over a five-year period.
Chapter 1: Deals by company
A comprehensive overview listing deals by company, with a full index of all
the deals announced. A clear and easy way to see the activities of any company.
Chapter 2: Deals by development stage
A review of deals by stage of development. Appreciate how deal values change
from discovery to launch in the therapy area.
Chapter 3: Deal type
Access deal information by type of transaction - see who is licensing or
partnering and using what type of deal.
Chapter 4: Industry sector
Deal announcements sorted by industry sector. Choose from nine sectors.
Chapter 5: Top 25 company profiles
Summary profiles for the most active companies in the therapy area over the
past five years, including contact details, business strategy, partnering
strategy, R&D and history.
Chapter 6: Detailed listing of deals and alliances
A full index of all the deals announced between Jan 2001 and Mar 2006. Every
deal entry includes a detailed deal description and financial information
where disclosed, such as headline values, upfront and milestone payments.
Every deal entry includes a detailed deal description and financial
information where disclosed, such as headline values, upfront and milestone
payments, and links to the full deal in the deal listing at the rear of each
report.
Table of Contents
Introduction
About Partneringdesk deals and alliances
Chapter 1: Deals in central nervous system diseases by company
Chapter 2: Deals in central nervous system diseases by development stage
Chapter 3: Deals in central nervous system diseases by type
Chapter 4: Deals in central nervous system diseases by industry sector
Chapter 5: Summary profiles for the most active companies in central nervous
system diseases
Chapter 6: List of deals
Glossary
